EMSY gene

Last updated on: 01.11.2021

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

EMSY is the acronym for "EMSY Transcriptional Repressor, BRCA2 Interacting" and refers to a protein-coding gene located on chromosome 11q13.5. The encoded protein acts as a regulator capable of repressing transcription, possibly via its interaction with a multiprotein chromatin restructuring complex that modifies chromatin . Its interaction with BRCA2 suggests that it may play a central role in the DNA repair function of BRCA2 (Hughes-Davies L et al. 2003; Rodriguez C et al. 2004). Mediates ligand-dependent transcriptional activation through nuclear hormone receptors.

PathophysiologyThis section has been translated automatically.

Diseases associated with EMSY include sporadic breast cancer and peanut allergy (Asai Yet al. 2018). Its related signaling pathways include the Mesodermal Commitment Pathway.

LiteratureThis section has been translated automatically.

  1. Asai Yet al. (2018) Genome-wide association study and meta-analysis in multiple populations identifies new loci for peanut allergy and establishes C11orf30/EMSY as a genetic risk factor for food allergy. J Allergy Clin Immunol 141:991-1001.
  2. Hughes-Davies L et al (2003) EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. Cell 115:523-535.
  3. Rodriguez C et al (2004) Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome. Clin Cancer Res 10:5785-5791.

Last updated on: 01.11.2021